1355346-75-6

Upstream product

• 1355031-15-0 4-(4-aminophenoxy)-6-methoxyquinolin-7-ol 
• 516526-32-2 4-(7-benzyloxy-6-methoxyquinolin-4-yloxy)aniline 
• 1355347-75-9 2-tert-butyl-4-(1-methyl-1H-pyrazol-5-yl)-1H-imidazole-5-carboxylic acid 
• 1355031-17-2 ethyl 2-((4-(4-aminophenoxy)-6-methoxyquinolin-7-yl)oxy)acetate 

Downstream Products

• 1355346-76-7 1-[2-tert-butyl-4-(1-methyl-1H-pyrazol-5-yl)-1H-imidazol-5-yl]-3-{4-[7-(2-hydroxyethoxy)-6-methoxyquinolin-4-yloxy]phenyl}urea 

Relevant academic research and scientific papers

NITROGENATED AROMATIC HETEROCYCLIC RING DERIVATIVE

The present invention provides a nitrogen-containing aromatic heterocyclic derivative represented by formula (I): [wherein W represents CR3 (wherein R3 represents a hydrogen atom or the like) or the like, R4 represents a hydrogen atom or the like, R5 represents a hydrogen atom or the like, R9 represents substituted imidazolyl, R12 and R13 may be the same or different, each represent a hydrogen atom or the like, R22 and R23 may be the same or different, each represent a hydrogen atom or the like, R24 represents a hydrogen atom or the like, Y represents C-R25 (wherein R25 represents a hydrogen atom or the like) or the like] or a pharmaceutically acceptable salt thereof and a FGFR inhibitor comprising, as an active ingredient, the nitrogen-containing aromatic heterocyclic derivative or the pharmaceutically acceptable salt thereof, or the like.